Phil Frost

Angel Investor Active United States
Last updated 2026-06-18
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
0
Rounds' value
$38.0M
total disclosed, rounds participated
Stages
—

Portfolio · 1

Eloxx Pharmaceuticals
Treatment of Rare Genetic Diseases
1 round $38.0M committed Latest: 2017-08

Investment activity

1 portfolio exit on record.

Portfolio by sector

Health Tech & Life Sciences1

Q&A

What is Phil Frost's primary investment focus?
Phil Frost primarily focuses on the Health Tech & Life Sciences sector, with all of his portfolio companies and exits being in this area.
Can you name a notable portfolio company of Phil Frost?
A notable portfolio company of Phil Frost is Eloxx Pharmaceuticals, which operates in the B2B business model and focuses on the treatment of rare genetic diseases.
What is the most recent exit for Phil Frost?
Phil Frost had an exit in April 2018 with Eloxx Pharmaceuticals, which went public on NASDAQ.
What was the funding stage of Phil Frost's investment in Eloxx Pharmaceuticals?
Phil Frost participated in a C Round investment for Eloxx Pharmaceuticals in August 2017.
What is the total amount raised by Eloxx Pharmaceuticals, a company in Phil Frost's portfolio?
Eloxx Pharmaceuticals has raised $98.5M in funding.